Cytokines as Biomarkers in Rheumatoid Arthritis
RA is a complex disease that develops as a series of events often referred to as disease continuum. RA would benefit from novel biomarker development for diagnosis where new biomarkers are still needed (even if progresses have been made with the inclusion of ACPA into the ACR/EULAR 2010 diagnostic c...
Saved in:
| Main Authors: | Agata Burska, Marjorie Boissinot, Frederique Ponchel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2014/545493 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
by: Agata N. Burska, et al.
Published: (2014-01-01) -
Biomarkers in Rheumatoid Arthritis
by: Vincent Goëb, et al.
Published: (2014-01-01) -
Clinical Biomarkers and Pathogenic-Related Cytokines in Rheumatoid Arthritis
by: Xiaoyin Niu, et al.
Published: (2014-01-01) -
Cytokine Signatures as Biomarkers of Clinical Remission in Rheumatoid Arthritis
by: Su W, et al.
Published: (2025-06-01) -
Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
by: Agata N Burska, et al.
Published: (2015-01-01)